Magnetic and Metal-Insulator Transitions in beta-Na0.5CoO2 and gamma-K0.5CoO2 -NMR and Neutron Diffraction Studies-

Co-oxides beta-Na0.5CoO2 and gamma-K0.5CoO2 have been prepared by the Na de-intercalation from alpha-NaCoO2 and by the floating-zone method, respectively. It has been found that successive phase transitions take place at temperatures Tc1 and Tc2 in both systems. The appearance of the internal magnetic field at Tc1 with decreasing temperature T indicates that the antiferromagnetic order exists at T < Tc1, as in gamma-Na0.5CoO2. For beta-Na0.5CoO2, the transition temperatures and the NMR parameters determined from the data taken for magnetically ordered state are similar to those of gamma-Na0.5CoO2, indicating that the difference of the stacking ways of the CoO2 layers between these systems do not significantly affect their physical properties. For gamma-K0.5CoO2, the quantitative difference of the physical quantities are found from those of beta- and gamma-Na0.5CoO2. The difference between the values of Tci (i = 1 and 2) of these systems might be explained by considering the distance between CoO2 layers.Comment: 8 pages, 14 figures, 1 Tabl

Precise Control of Band Filling in NaxCoO2

Electronic properties of the sodium cobaltate NaxCoO2 are systematically studied through a precise control of band filling. Resistivity, magnetic susceptibility and specific heat measurements are carried out on a series of high-quality polycrystalline samples prepared at 200 C with Na content in a wide range of 0.35 =< x =< 0.70. It is found that dramatic changes in electronic properties take place at a critical Na concentration x* that lies between 0.58 and 0.59, which separates a Pauli paramagnetic and a Curie-Weiss metals. It is suggested that at x* the Fermi level touches the bottom of the a1g band at the gamma point, leading to a crucial change in the density of states across x* and the emergence of a small electron pocket around the gamma point for x > x*.Comment: 4 pages, 5 figures, submitted to J. Phys. Soc. Jp

Bulk antiferromagnetism in Na0.82CoO2\bf Na_{0.82}CoO_2 single crystals

Susceptibility, specific heat, and muon spin rotation measurements on high-quality single crystals of $\rm Na_{0.82}CoO_2$ have revealed bulk antiferromagnetism with N\'{e}el temperature $\rm T_N = 19.8 \pm 0.1$ K and an ordered moment perpendicular to the $\rm CoO_2$ layers. The magnetic order encompasses nearly 100% of the crystal volume. The susceptibility exhibits a broad peak around 30 K, characteristic of two-dimensional antiferromagnetic fluctuations. The in-plane resistivity is metallic at high temperatures and exhibits a minimum at $\rm T_N$.Comment: published versio

Mass-Enhanced Fermi Liquid Ground State in Na1.5_{1.5}Co2_2O4_4

Magnetic, transport, and specific heat measurements have been performed on layered metallic oxide Na$_{1.5}$Co$_2$O$_4$ as a function of temperature $T$. Below a characteristic temperature $T^*$=30$-$40 K, electrical resistivity shows a metallic conductivity with a $T^2$ behavior and magnetic susceptibility deviates from the Curie-Weiss behavior showing a broad peak at $\sim$14 K. The electronic specific heat coefficient $\gamma$ is $\sim$60 mJ/molK$^2$ at 2 K. No evidence for magnetic ordering is found. These behaviors suggest the formation of mass-enhanced Fermi liquid ground state analogous to that in $d$-electron heavy fermion compound LiV$_2$O$_4$.Comment: 4 pages, 4 figures, to be published in Phys. Rev. B 69 (2004

Impurity-induced transition and impurity-enhanced thermopower in the thermoelectric oxide NaCo_{2-x}Cu_x$O_4

Various physical quantities are measured and analysed for the Cu-substituted thermoelectric oxide NaCo_{2-x}Cu_xO_4. As was previously known, the substituted Cu enhances the thermoelectric power, while it does not increase the resistivity significantly. The susceptibility and the electron specific-heat are substantially decreased with increasing x, which implies that the substituted Cu decreases the effective-mass enhancement. Through a quantitative comparison with the heavy fermion compounds and the valence fluctuation systems, we have found that the Cu substitution effectively increases the coupling between the conduction electron and the magnetic fluctuation. The Cu substitution induces a phase transition at 22 K that is very similar to a spin-density-wave transition.Comment: 8 pages, 7 figures, submitted to Phys. Rev.

Effect of Na content and hydration on the excitation spectrum of the cobaltite Na_xCoO_2 yH_2O

We report on a Raman scattering study on the superconducting cobaltite $Na_xCoO_2\cdot yH_2O$ as function of Na content and hydration (x$\approx$1/3, 3/4 and y$\approx$0, 2/3, 4/3). The observed phonon scattering and scattering continua are analyzed in terms of lattice strain due to the structural misfit and disorder. Hydration, due to the intercalation of one or two $H_2O$ layers, releases a part of this strain. Our Raman data suggest a connection between disorder on the partly occupied Na sites, the split off of the $a_{1g}$ level from the other $t_{2g}$ states of $Co^{4+}$ and superconductivity.Comment: 10 pages, 4 figures, for further information see http://www.peter-lemmens.d

Unconventional magnetic transition and transport behavior in Na0.75CoO2

Here we report an unconventional magnetic and transport phenomenon in a layered cobalt oxide, NaxCoO2. Only for x = 0.75, a magnetic transition of the second order was clearly detected at Tm ~ 22 K where an apparent specific-heat jump, an onset of extremely small spontaneous magnetization, and a kink in resistivity came in. Moreover large positive magnetoresistance effect was observed below Tm. These features of the transition strongly indicate the appearance of an unusual electronic state that may be attributed to the strongly-correlated electrons in Na0.75CoO2.Comment: 5 pages, 6 figures, to appear in Phys. Rev.

Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene

Low phospholipid-associated cholelithiasis (LPAC) is characterized by the association of ABCB4 mutations and low biliary phospholipid concentration with symptomatic and recurring cholelithiasis. This syndrome is infrequent and corresponds to a peculiar small subgroup of patients with symptomatic gallstone disease. The patients with the LPAC syndrome present typically with the following main features: age less than 40 years at onset of symptoms, recurrence of biliary symptoms after cholecystectomy, intrahepatic hyperechoic foci or sludge or microlithiasis along the biliary tree. Defect in ABCB4 function causes the production of bile with low phospholipid content, increased lithogenicity and high detergent properties leading to bile duct luminal membrane injuries and resulting in cholestasis with increased serum gamma-glutamyltransferase (GGT) activity. Intrahepatic gallstones may be evidenced by ultrasonography (US), computing tomography (CT) abdominal scan or magnetic resonance cholangiopancreatography, intrahepatic hyperechogenic foci along the biliary tree may be evidenced by US, and hepatic bile composition (phospholipids) may be determined by duodenoscopy. In all cases where the ABCB4 genotyping confirms the diagnosis of LPAC syndrome in young adults, long-term curative or prophylactic therapy with ursodeoxycholic acid (UDCA) should be initiated early to prevent the occurrence or recurrence of the syndrome and its complications. Cholecystectomy is indicated in the case of symptomatic gallstones. Biliary drainage or partial hepatectomy may be indicated in the case of symptomatic intrahepatic bile duct dilatations filled with gallstones. Patients with end-stage liver disease may be candidates for liver transplantation

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

[EN] Cholangiocarcinoma (CCA) includes a cluster of highly heterogeneous biliary malignant tumours that can arise at any point of the biliary tree. Their incidence is increasing globally, currently accounting for ~15% of all primary liver cancers and ~3% of gastrointestinal malignancies. The silent presentation of these tumours combined with their highly aggressive nature and refractoriness to chemotherapy contribute to their alarming mortality, representing ~2% of all cancer-related deaths worldwide yearly. The current diagnosis of CCA by non- invasive approaches is not accurate enough, and histological confirmation is necessary. Furthermore, the high heterogeneity of CCAs at the genomic, epigenetic and molecular levels severely compromises the efficacy of the available therapies. In the past decade, increasing efforts have been made to understand the complexity of these tumours and to develop new diagnostic tools and therapies that might help to improve patient outcomes. In this expert Consensus Statement, which is endorsed by the European Network for the Study of Cholangiocarcinoma, we aim to summarize and critically discuss the latest advances in CCA, mostly focusing on classification, cells of origin, genetic and epigenetic abnormalities, molecular alterations, biomarker discovery and treatments. Furthermore, the horizon of CCA for the next decade from 2020 onwards is highlightedJ.M.B. received EASL Registry Awards 2016 and 2019 (European CCA Registry, ENS-CCA). J.M.B. and M.J.P. were supported by: the Spanish Ministry of Economy and Competitiveness (J.M.B.: FIS PI12/00380, FIS PI15/01132, FIS PI18/01075 and Miguel Servet Programme CON14/00129; M.J.P.: FIS PI14/00399, FIS PI17/00022 and Ramon y Cajal Programme RYC-2015-17755, co-financed by “Fondo Europeo de Desarrollo Regional” (FEDER)); ISCIII CIBERehd; “Diputación Foral de Gipuzkoa” (J.M.B: DFG15/010, DFG16/004), and BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia BIO15/CA/016/BD); the Department of Health of the Basque Country (M.J.P.: 2015111100; J.M.B.: 2017111010), and “Fundación Científica de la Asociación Española Contra el Cancer” (AECC Scientific Foundation) (J.M.B.). J.M.B. and J.W.V. were supported by the European Commission Horizon 2020 programme (ESCALON project 825510). The laboratory of J.B.A. is supported by competitive grants from the Danish Medical Research Council, the Danish Cancer Society, and the Novo Nordisk and A.P. Møller Foundations. J.J.G.M. and R.I.R.M. were supported by the Carlos III Institute of Health, Spain (PI16/00598 and PI18/00428) and were co-financed by the European Regional Development Fund. J.M.B. and J.J.G.M. were supported by the Ministry of Science and Innovation, Spain (SAF2016-75197-R), and the “Asociación Española Contra el Cancer”, Spain (AECC-2017). R.I.R.M. was supported by the “Centro Internacional sobre el Envejecimiento”, Spain (OLD-HEPAMARKER, 0348-CIE-6-E). A.L. received funding from the Christie Charity. M.M. was supported by the Università Politecnica delle Marche, Ancona, Italy (040020_R.SCIENT.A_2018_MARZIONI_M_STRATEGICO_2017). M.S. was supported by the Yale Liver Center Clinical and Translational Core and the Cellular and Molecular Core (DK034989 Silvio O. Conte Digestive Diseases Research Center). C.C. is supported by grants from INSERM, Université de Rennes, INCa, and ITMO Cancer AVIESAN dans le cadre du Plan Cancer (Non-coding RNA in Cancerology: Fundamental to Translational), Ligue Contre le Cancer and Région Bretagne. J.Bruix was supported by grants from Instituto de Salud Carlos III (PI18/00763), AECC (PI044031) and WCR (AICR) 16-0026. A.F. was supported by grants from ISCIII (PI13/01229 and PI18/00542). CIBERehd is funded by the Instituto de Salud Carlos III. V.C., D.M., J. Bridgewater and P.I. are members of the European Reference Network - Hepatological Diseases (ERN RARE-LIVER). J.M.B. is a collaborator of the ERN RARE-LIVER

Achieving Controlled Biomolecule-Biomaterial Conjugation

The conjugation of biomolecules can impart materials with the bioactivity necessary to modulate specific cell behaviors. While the biological roles of particular polypeptide, oligonucleotide, and glycan structures have been extensively reviewed, along with the influence of attachment on material structure and function, the key role played by the conjugation strategy in determining activity is often overlooked. In this review, we focus on the chemistry of biomolecule conjugation and provide a comprehensive overview of the key strategies for achieving controlled biomaterial functionalization. No universal method exists to provide optimal attachment, and here we will discuss both the relative advantages and disadvantages of each technique. In doing so, we highlight the importance of carefully considering the impact and suitability of a particular technique during biomaterial design